GL1X · GenesisL1 explorer

MolNFT v1 · #108789 · protein

Structural mapping of the human IGG1 binding site for fcrn: HU3S193 Fc mutation H310A

4WI5 · Ig gamma-1 chain C region: “Structural mapping of the human IGG1 binding site for fcrn: HU3S193 Fc mutation H310A”. X-ray diffraction, 4 ligands (NAG, MAN, BMA), 1 pocket (best druggability 0.31). MolNFT v1 #108789 on GenesisL1: 3D…

PDB
4WI5
Type
protein
Length
416 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ig gamma-1 chain C region
UniProt
P01857
Ligands
NAG, MAN, BMA, FUC
Pockets
1 · best druggability 0.31

Structure

x-ray diffraction · 1 distinct chain · 11% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIg gamma-1 chain C regionprotein20811% helix, 47% strandP01857

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 4 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains A, B
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.310.7321empty

Interfaces

1 interface between chains.

  • A–B · 1193 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 4WI5 · Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.